The least-squares mean change in A1c was significant compared with placebo in all three LY dosing groups: LY0.5/1 = -1.38%, LY1/1 = -1.32%, LY1/2 = -1.59%. The reduction seen with LY1/2 was also ...

Individual participant data were obtained for 103 trials: 103 reported hemoglobin A1c (HbA1c), and six ... while the relative reduction with GLP-1 receptor agonist use was less in older versus ...

While NationsBenefits does not prescribe GLP-1 medications ... programs have achieved an average 6% weight loss and a 1.5-point A1c reduction. Additionally, 68% of health plan members who received ...

Longer-acting glucagon-like peptide-1 (GLP-1) receptor agonists and devices ... in several studies to produce equal or greater reduction in A1c and weight compared with the standard twice-daily ...